National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 61009 [2012-24579]
Download as PDF
<![CDATA[
61009
Federal Register / Vol. 77, No. 194 / Friday, October 5, 2012 / Notices
Estimated
number of
respondents
Type of respondent
Estimated
number of responses per
respondent
Average
burden per
response
(in hours)
Estimated total
annual burden
hours
Study Registration and Data Submission
PI ......................................................................................................................
Senior Official ..................................................................................................
50
50
1
1
45/60
30/60
38
25
Total ..........................................................................................................
100
........................
........................
63
PI ......................................................................................................................
Senior Official ..................................................................................................
633
633
2
2
45/60
30/60
950
633
Total ..........................................................................................................
1,266
........................
........................
1,583
Data Access Request
Request For Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
To
request additional information on the
proposed information collection,
contact: Sarah Carr, Acting Director,
Office of Clinical Research and
Bioethics Policy, Office of Science
Policy, NIH, 6705 Rockledge Drive,
Suite 750, Bethesda, MD 20892;
telephone 301–496–9838; fax 301–496–
9839; or email GWAS@mail.nih.gov,
Attention: Ms. Carr.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication. Comments should be
directed to Ms. Carr through the contact
information above.
pmangrum on DSK3VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Dated: September 28, 2012.
Sarah Carr,
Acting Director, Office of Clinical Research
and Bioethics Policy, Office of Science Policy,
NIH.
[FR Doc. 2012–24623 Filed 10–4–12; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:25 Oct 04, 2012
Jkt 229001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: October 1, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–24579 Filed 10–4–12; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the public
in accordance with the provisions set
forth in sections 552b(c)(4) and
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Resource Related
Research Projects for AIDS, Allergy,
Immunology & Transplantation.
Date: October 25, 2012.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Dharmendar Rathore,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Rm. 3134, Bethesda, MD 20892–7616, 301–
435–2766, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Immunologic Mechanisms.
Date: October 17, 2012.
Time: 10 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Stephen M. Nigida, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212,
MSC 7812, Bethesda, MD 20892, 301–435–
1222, nigidas@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 77, Number 194 (Friday, October 5, 2012)]
[Notices]
[Page 61009]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24579]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting. The meeting will be closed to the public in accordance with
the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Resource Related Research
Projects for AIDS, Allergy, Immunology & Transplantation.
Date: October 25, 2012.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817.
Contact Person: Dharmendar Rathore, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Rm. 3134, Bethesda, MD 20892-7616, 301-435-2766,
rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 1, 2012.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-24579 Filed 10-4-12; 8:45 am]
BILLING CODE 4140-01-P
